This invention relates to compounds of the formula ##STR00001## wherein B, X, Y, Z, R.sup.1 and R.sup.2 are as defined in the description, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by ACC.beta. inhibitors.